Physician profile

Owen Mogabgab

Cardiovascular Disease · Luling, LA

NPI 1669528915

$30,882.76

in general payments reported to CMS, 2019-2025

41 companies · $1,442 in 2025

The $1,442 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,815.89
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$6,700.00
Consulting Fee$700.00
Education$21.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $18,249.40 2019-2025 Farxiga, Wainua
Medtronic, INC. $1,406.31 2021-2025 Corevalve Evolut R, Hawkone, Symplicity G3
Angiodynamics, INC. $1,377.37 2023-2025 Auryon Laser System 100-120 Vac, Alphavac
Terumo Medical Corporation $1,326.69 2020-2024 Navicross, R2p Misago, Glidesheath Slender
Abiomed $854.81 2019-2025 Impella
Janssen Pharmaceuticals, INC $796.93 2019-2024 Xarelto
Abbott Laboratories $703.76 2019-2025 Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Supera
Novartis Pharmaceuticals Corporation $665.80 2019-2025
Boston Scientific Corporation $613.23 2019-2025 Stingray, Watchman Flx
Amgen INC. $478.38 2019-2025 Repatha, Repatha
Novo Nordisk INC $393.95 2022-2025 Ozempic, Wegovy, Rybelsus
Inari Medical, INC. $377.98 2019-2022
Merck Sharp & Dohme LLC $370.65 2022-2025 Verquvo
Imperative Care, INC $364.55 2023 Symphony Catheter, Prodigy Catheter
Pfizer INC. $312.70 2019-2025
Show all 41 companies
CompanyGeneral paymentsYearsTop products
E.R. Squibb & Sons, L.L.C. $253.78 2019-2025 Camzyos, Eliquis
Boehringer Ingelheim Pharmaceuticals, INC. $224.02 2019-2024 Jardiance
W. L. Gore & Associates, INC. $223.14 2019-2021
Shockwave Medical, INC $177.02 2023 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Atricure, INC. $144.56 2022-2025 Synergy Ablation System
Cardiovascular Systems INC. $137.73 2022
Chiesi USA, INC. $134.33 2019
Esperion Therapeutics, INC. $129.18 2022-2025 Nexletol
Penumbra, INC. $121.78 2024 Penumbra System
Asahi Intecc USA, INC. $120.96 2022
Philips North America LLC $112.28 2022
Regeneron Healthcare Solutions, INC. $110.69 2019-2024 Evkeeza
Alnylam Pharmaceuticals INC. $107.26 2022-2024 Onpattro
Lexicon Pharmaceuticals, INC. $107.08 2023-2024 Inpefa
Bayer Healthcare Pharmaceuticals INC. $86.96 2021-2023
Sanofi-Aventis U.S. LLC $85.95 2019-2022
Surmodics, INC. $81.26 2025 Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight
Kestra Medical Technology Services, INC. $41.34 2023 Assure Wcd
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $39.36 2021-2023 Lifevest
Cook Medical LLC $35.58 2019
Itamar Medical INC $32.40 2022-2023 Watchpatone
Impulse Dynamics (USA) INC. $20.07 2022
Arbor Pharmaceuticals, INC. $17.81 2019
Cordis US Corp. $16.13 2024 Mynx Control
Biotronik INC. $14.80 2022
Lilly USA, LLC $14.78 2025 Zepbound, Mounjaro

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Owen Mogabgab

$30,882.76

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $1,442 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/165883/owen-mogabgab

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.